To further understand how signaling bias at both the GLP-1 and GIP receptors would improve the efficacy of pharmacological agents for the treatment of overweight and obesity, we used Chemotype Evolution (a high-throughput, iterative, nanoliter scale chemistry and screening platform developed by Carmot Therapeutics Inc
Because semaglutide reduces portion sizes naturally, most patients find watermelon fits easily into their protocol without blood sugar spikes
Protein Requirements for Breastfeeding Mothers Breastfeeding is metabolically demanding
The gut microbiota and oxidative stress in autism spectrum disorders (ASD)
Our services as a weight loss clinic that takes insurance distinguish us, allowing you to start your weight loss journey without unnecessary delays
Fewer Disease Flares With GLP-1 Therapy In a retrospective study led by Shreya Sakthivel, Chief Resident of Internal Medicine at Anne Arundel Medical Center, investigators found that RA patients receiving disease-modifying antirheumatic drugs (DMARDs) who also took GLP-1 receptor agonists or SGLT2 inhibitors experienced fewer disease flares than those on DMARDs alone
